Nisa Investment Advisors
CLVS

Nisa Investment Advisors’s Clovis Oncology, Inc. CLVS Stock Holding History

Nisa Investment Advisors’s Portfolio CLVS Stock Details CLVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-169,345
Closed -$342K – 2551
2022
Q1 		$342K Buy
169,345
+168,000
+12,491% +$330K ﹤0.01% 1190
2021
Q4 		$3K Hold
1,345
– – ﹤0.01% 2120
2021
Q3 		$6 Hold
1,345
– – ﹤0.01% 2251
2021
Q2 		$8 Sell
1,345
-5,300
-80% -$31.1K ﹤0.01% 2256
2021
Q1 		$47 Buy
6,645
+5,300
+394% +$35.5K ﹤0.01% 1994
2020
Q4 		$6K Buy
1,345
+700
+109% +$3.54K ﹤0.01% 2261
2020
Q3 		$4K Hold
645
– – ﹤0.01% 2217
2020
Q2 		$4K Buy
645
+175
+37% +$1.32K ﹤0.01% 2031
2020
Q1 		$3K Sell
470
-47,830
-99% -$384K ﹤0.01% 2033
2019
Q4 		$504K Buy
48,300
+46,600
+2,741% +$339K ﹤0.01% 1092
2019
Q3 		$7K Buy
1,700
+1,500
+750% +$12.1K ﹤0.01% 1859
2019
Q2 		$3K Hold
200
– – ﹤0.01% 1959
2019
Q1 		$5K Sell
200
-400
-67% -$10K ﹤0.01% 1924
2018
Q4 		$11K Buy
600
+370
+161% +$7.56K ﹤0.01% 1637
2018
Q3 		$7K Sell
230
-20
-8% -$774 ﹤0.01% 1821
2018
Q2 		$11K Hold
250
– – ﹤0.01% 1715
2018
Q1 		$13K Sell
250
-50
-17% -$2.92K ﹤0.01% 1580
2017
Q4 		$20K Hold
300
– – ﹤0.01% 1550
2017
Q3 		$25K Hold
300
– – ﹤0.01% 1492
2017
Q2 		$28K Buy
300
+140
+88% +$8.57K ﹤0.01% 1445
2017
Q1 		$10K Sell
160
-140
-47% -$8.51K ﹤0.01% 1677
2016
Q4 		$13K Hold
300
– – ﹤0.01% 1760
2016
Q3 		$11K Sell
300
-1,700
-85% -$36.5K ﹤0.01% 1788
2016
Q2 		$27K Buy
2,000
+1,700
+567% +$24.8K ﹤0.01% 1517
2016
Q1 		$6K Buy
+300
New +$6.35K ﹤0.01% 1834
2015
Q4 		– Sell
-8,100
Closed -$745K – 1270
2015
Q3 		$745K Hold
8,100
– – 0.01% 831
2015
Q2 		$712K Hold
8,100
– – 0.01% 903
2015
Q1 		$601K Buy
8,100
+300
+4% +$21.2K 0.01% 984
2014
Q4 		$437K Hold
7,800
– – 0.01% 1052
2014
Q3 		$354K Buy
+7,800
New +$326K 0.01% 1101

Other funds holding CLVS

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
QF
QVT Financial New York $1.37B AUM 148.1% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
E
Ergoteles New York $68.2M AUM 36.16% 1-Year Est. Return
PA
Pinnacle Associates New York $7.78B AUM 45.07% 1-Year Est. Return

Nisa Investment Advisors's CLVS Position: Q2 2022 in Review

Nisa Investment Advisors sold out of Clovis Oncology, Inc. (CLVS) in Q2 2022, closing a stake of 169,345 shares — an estimated $342K sold.

Nisa Investment Advisors first reported a position in CLVS in Q3 2014 and held it in 30 quarters. The position peaked at $745K in Q3 2015. 115 funds tracked by Wall St. Rank hold CLVS as of Q2 2022.

  • Nisa Investment Advisors reported no remaining Clovis Oncology, Inc. position as of Q2 2022 after selling out during the quarter.
  • Nisa Investment Advisors sold 169,345 Clovis Oncology, Inc. shares in Q2 2022, an estimated $342K.
  • Nisa Investment Advisors first reported a position in Clovis Oncology, Inc. in Q3 2014 and held it in 30 quarters.
  • Nisa Investment Advisors's Clovis Oncology, Inc. position peaked at $745K in Q3 2015.
  • 115 funds tracked by Wall St. Rank held Clovis Oncology, Inc. as of Q2 2022.

Based on Nisa Investment Advisors's 13F filing for Q2 2022, filed 3 Aug 2022.